gazyva solution
hoffmann-la roche limited - obinutuzumab - solution - 25mg - obinutuzumab 25mg - antineoplastic agents
opdivo solution
bristol-myers squibb canada - nivolumab - solution - 10mg - nivolumab 10mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 24mg - lenvatinib (mésylate de lenvatinib) 24mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 20mg - lenvatinib (mésylate de lenvatinib) 20mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 14mg - lenvatinib (mésylate de lenvatinib) 14mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 10mg - lenvatinib (mésylate de lenvatinib) 10mg - antineoplastic agents
darzalex solution
janssen inc - daratumumab - solution - 100mg - daratumumab 100mg - antineoplastic agents
tecentriq solution
hoffmann-la roche limited - atÉzolizumab - solution - 1200mg - atÉzolizumab 1200mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 8mg - lenvatinib (mésylate de lenvatinib) 8mg - antineoplastic agents
lenvima capsule
eisai limited - lenvatinib (mésylate de lenvatinib) - capsule - 18mg - lenvatinib (mésylate de lenvatinib) 18mg - antineoplastic agents